Basel, 18 January 2017
Reminder: Invitation to Roche's Full Year Results 2016
Roche will publish its Full Year Results for 2016 prior to the opening of the Swiss Stock Exchange on Wednesday, 1 February 2017.
7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)
Release will be e-mailed and posted on the Roche IR website click here.
Presentation slides will be posted on the Roche IR website click here.
We would like to invite all interested parties to participate or dial in to the event outlined below.
Wednesday, 1 February 2017, London
The Full Year Presentation followed by Q&A and additional break-out sessions will be held at the
London Stock Exchange, The Theatre, 10 Paternoster Square, London EC4M 7LS map
- Severin Schwan, CEO Roche Group
- Daniel O’Day, CEO Roche Pharmaceuticals
- Roland Diggelmann, CEO Roche Diagnostics
- Alan Hippe, Chief Financial and IT Officer
Date: 1 February 2017
15:00 Meeting starts
17:30 Meeting ends, followed by a buffet reception
Break-out sessions covering the topics Strategy, Finance & Accounting, Pharmaceuticals and Diagnostics will be held following the main Q&A.
Following the event we would also like to invite you to drinks and canapés to give you the opportunity to speak to management more informally.
Please make sure you have identification and allow enough time to go through the London Stock Exchange security check.
Alternatively, you may dial in to the conference, using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start:
+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)
To expedite the registration process on the day of the event, you may pre-register for the conference call. click here.
A replay of the video webcast will be available on demand on the Roche website. click here